Effects of Integrated Multicomponent Care on Older Adults With Frailty or Pre-Frailty: A Systematic Review and Meta-Analysis.
Kexin Huang, Shuang Li, Qinghuan Kong et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review and meta-analysis assessed integrated multicomponent care (IMC) for older adults with frailty or pre-frailty, including evidence from 20 randomised and quasi-experimental studies. In six studies reporting frailty improvement, IMC did not show a statistically significant advantage over control (RR = 1.20, 95% CI: 0.97-1.49; p = 0.092). Pooled results also showed no statistically significant differences in activities of daily living, health-related quality of life, mortality or rehospitalizations. The authors conclude that evidence for benefit remains inconclusive and call for further high-quality research with longer follow-up.
Key findings
- Frailty improvement was not significantly different with IMC versus control across six studies (RR = 1.20, 95% CI: 0.97-1.49; p = 0.092).
- ADL outcomes numerically favoured IMC, but the pooled difference was not significant (SMD = 0.61, 95% CI: -0.11 to 1.34; I 2 = 95.1%).
- No significant differences were found for health-related QoL (SMD = 0.00, 95% CI: -0.16-0.15), mortality (RR = 0.95, 95% CI: 0.84-1.09) or rehospitalizations (RR = 1.00, 95% CI: 0.79-1.26).
Why it matters
Frailty care addresses multiple needs, but this synthesis does not establish that integrated multicomponent approaches improve frailty or daily function, or affect quality of life and major health outcomes. The findings help clarify the current uncertainty around these care models and underscore the need to evaluate whether any benefits are clinically meaningful.
What to keep in mind
The evidence base included randomised and quasi-experimental studies; ADL estimates came from only three studies and showed substantial heterogeneity (I 2 = 95.1%). The authors call for higher-quality research with longer follow-up.